The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Molecular and Pathologic Aspects of Endometrial Carcinogenesis
Abstract
Endometrial cancer is the most common gynecological malignancy, with 41,000 new cases projected in the United States for 2006. Two different clinicopathologic subtypes are recognized: the estrogen-related (type I, endometrioid) and the non–estrogen-related types (type II, nonendometrioid such as papillary serous and clear cell). The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy and p53 mutations. This article reviews the genetic aspects of endometrial carcinogenesis and progression. We will define the precursor lesion of type I endometrioid cancer and the role of genetics and estrogen in its progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Two pathogenetic types of endometrial carcinoma
Bokhman, J. V. (1983) · Gynecologic Oncology · doi:10.1016/0090-8258(83)90111-7 · Cited by 2,494
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422
Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer
Gryfe, R., Kim, H., Hsieh, E. T. K., Aronson, M. D., Holowaty, E. J., Bull, S. B., Redston, M., & Gallinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420201 · Cited by 1,388
Association of the APC Tumor Suppressor Protein with Catenins
Su, L.-K., Vogelstein, B., & Kinzler, K. W. (1993) · Science · doi:10.1126/science.8259519 · Cited by 1,188
Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers
Mutter, G. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.924 · Cited by 829
Self-citationColler, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R. E., & Ellenson, L. H. (1997) · PubMed · Cited by 701
β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer
Brabletz, T., Jung, A., Dag, S., Hlubek, F., & Kirchner, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65204-2 · Cited by 671
Genetic instability of microsatellites in endometrial carcinoma.
Risinger, J. I., Berchuck, A., Kohler, M. F., Watson, P. A., Lynch, H. T., & Boyd, J. A. (1993) · PubMed · Cited by 517
PTEN/MMAC1 mutations in endometrial cancers.
Risinger, J. I., Hayes, A. K., Berchuck, A., & Barrett, J. C. (1997) · PubMed · Cited by 506
Esteller, M., Levine, R., Baylin, S. B., Ellenson, L. H., & Herman, J. G. (1998) · Oncogene · doi:10.1038/sj.onc.1202178 · Cited by 493
High Frequency of Coexistent Mutations of PIK3CA and PTEN Genes in Endometrial Carcinoma
Oda, K., Stokoe, D., Taketani, Y., & McCormick, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2620 · Cited by 466
The epidemiology of endometrial cancer
Parazzini, F., La Vecchia, C., Bocciolone, L., & Franceschi, S. (1991) · Gynecologic Oncology · doi:10.1016/0090-8258(91)90246-2 · Cited by 400
Zorn, K. K., Bonome, T., Gangi, L., Chandramouli, G. V. R., Awtrey, C. S., Gardner, G. J., Barrett, J. C., Boyd, J., & Birrer, M. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0508 · Cited by 376
Beta-catenin mutation in carcinoma of the uterine endometrium.
Fukuchi, T., Sakamoto, M., Tsuda, H., Maruyama, K., Nozawa, S., & Hirohashi, S. (1998) · PubMed · Cited by 361
High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.
Stambolic, V., Tsao, M., MacPherson, D. P., Suzuki, A., Chapman, W. B., & Mak, T. W. (2000) · PubMed · Cited by 356
Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas.
Palacios, J., & Gamallo, C. (1998) · PubMed · Cited by 344
Sherman, M. E., Bur, M. E., & Kurman, R. J. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90204-x · Cited by 342
PTEN1 is frequently mutated in primary endometrial carcinomas
Kong, D., Suzuki, A., Zou, T.-T., Sakurada, A., Kemp, L. W., Wakatsuki, S., Yokoyama, T., Yamakawa, H., Furukawa, T., Sato, M., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-143 · Cited by 337
hMLH1 Promoter Hypermethylation Is an Early Event in Human Endometrial Tumorigenesis
Esteller, M., Catasus, L., Matias-Guiu, X., Mutter, G. L., Prat, J., Baylin, S. B., & Herman, J. G. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65492-2 · Cited by 304
Self-citationMolecular pathology of endometrial hyperplasia and carcinoma
Matias-guiu, X., Catasus, L., Bussaglia, E., Lagarda, H., Garcia, A., Pons, C., Muñoz, J., Argüelles, R., Machin, P., & Prat, J. (2001) · Human Pathology · doi:10.1053/hupa.2001.25929 · Cited by 301
Endometrial Intraepithelial Neoplasia (EIN): Will It Bring Order to Chaos?
Mutter, G. L. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5580 · Cited by 298
Self-citationCase--Control Study of Endogenous Steroid Hormones and Endometrial Cancer
Potischman, N., Hoover, R. N., Brinton, L. A., Siiteri, P., Dorgan, J. F., Swanson, C. A., Berman, M. L., Mortel, R., Twiggs, L. B., Barrett, R. J., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1127 · Cited by 297
Levine, R. L., Cargile, C. B., Blazes, M. S., van Rees, B. P., Kurman, R. J., & Ellenson, L. H. (1998) · PubMed · Cited by 295
A PANorama of PAX genes in cancer and development
Robson, E. J. D., He, S.-J., & Eccles, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1778 · Cited by 283
Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis
Wu, H., Chen, Y., Liang, J., Shi, B., Wu, G., Zhang, Y., Wang, D., Li, R., Yi, X., Zhang, H., et al. (2005) · Nature · doi:10.1038/nature04225 · Cited by 273
Mirabelli-Primdahl, L., Gryfe, R., Kim, H., Millar, A. H., Luceri, C., Dale, D., Holowaty, E. J., Bapat, B. V., Gallinger, S., & Redston, M. S. (1999) · PubMed · Cited by 259
Zaino, R. J., Kauderer, J., Trimble, C. L., Silverberg, S. G., Curtin, J. P., Lim, P. C., & Gallup, D. G. (2006) · Cancer · doi:10.1002/cncr.21649 · Cited by 253
Kurose, K., Zhou, X.-P., Araki, T., Cannistra, S. A., Maher, E. R., & Eng, C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64681-0 · Cited by 252
Goodfellow, P. J., Buttin, B. M., Herzog, T. J., Rader, J. S., Gibb, R. K., Swisher, E., Look, K., Walls, K. C., Fan, M.-Y., & Mutch, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1030231100 · Cited by 237
Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
Maxwell, G. L., Risinger, J. I., Gumbs, C. E., Shaw, H., Bentley, R. C., Barrett, J. C., Berchuck, A., & Futreal, P. A. (1998) · PubMed · Cited by 231
Schwartz, S., Yamamoto, H., Navarro, M., Maestro, M. L., Reventós, J., & Perucho, M. (1999) · PubMed · Cited by 229
Causes and consequences of microsatellite instability in endometrial carcinoma.
Gurin, C. C., Federici, M. G., Kang, L., & Boyd, J. A. (1999) · PubMed · Cited by 215
Baak, J. P., Mutter, G. L., Robboy, S., van Diest, P. J., Uyterlinde, A. M., Ørbo, A., Palazzo, J., Fiane, B., Løvslett, K., Burger, C., et al. (2005) · Cancer · doi:10.1002/cncr.21058 · Cited by 213
Self-citationRisinger, J. I., Maxwell, G. L., Chandramouli, G. V. R., Jazaeri, A. A., Aprelikova, O. N., Patterson, T., Berchuck, A., & Barrett, J. C. (2003) · PubMed · Cited by 208
Primary prevention of gynecologic cancers
Grimes, D. A., & Economy, K. E. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90125-6 · Cited by 207
Molecular identification of latent precancers in histologically normal endometrium.
Mutter, G. L., Ince, T. A., Baak, J. P. A., Kust, G. A., Zhou, X. P., & Eng, C. (2001) · PubMed · Cited by 204
Self-citationEndometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry
Mutter, G. L., Baak, J. P. A., Crum, C. P., Richart, R. M., Ferenczy, A., & Faquin, W. C. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200003)190:4<462::aid-path590>3.0.co;2-d · Cited by 195
Self-citationCatasús, L., Bussaglia, E., Rodrı́guez, I., Gallardo, A., Pons, C., Irving, J. A., & Prat, J. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.07.019 · Cited by 181
Peiffer, S. L., Herzog, T. J., Tribune, D. J., Mutch, D. G., Gersell, D. J., & Goodfellow, P. J. (1995) · PubMed · Cited by 179
Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.
Sasaki, H., Nishii, H., Takahashi, H., Tada, A., Furusato, M., Terashima, Y., Siegal, G. P., Parker, S. L., Kohler, M. F., & Berchuck, A. (1993) · PubMed · Cited by 176
Use of oral contraceptives and endometrial cancer risk (Sweden)
Weiderpass, E., Adami, H., Baron, J. A., Magnusson, C., Lindgren, A., & Persson, I. R. (1999) · Cancer Causes & Control · doi:10.1023/a:1008945721786 · Cited by 176
Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair
Risinger, J. I., Umar, A., Boyd, J., Berchuck, A., Kunkel, T. A., & Barrett, J. C. (1996) · Nature Genetics · doi:10.1038/ng0996-102 · Cited by 176
β- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis
Saegusa, M., Hashimura, M., Yoshida, T., & Okayasu, I. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1581 · Cited by 168
Changes in Endometrial PTEN Expression throughout the Human Menstrual Cycle
Mutter, G. L., Lin, M.-C., Fitzgerald, J. T., Kum, J. B., & Eng, C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6652 · Cited by 166
Self-citationPostmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study
Zeleniuch-Jacquotte, A., Akhmedkhanov, A., Kato, I., Koenig, K. L., Shore, R. E., Kim, M. Y., Levitz, M., Mittal, K. R., Raju, U., Banerjee, S., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1704 · Cited by 158
Ouyang, H. W., Shiwaku, H. O., Hagiwara, H., Miura, K., Abe, T., Kato, Y., Ohtani, H., Shiiba, K., Souza, R. F., Meltzer, S. J., et al. (1997) · PubMed · Cited by 157
K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto, T., Inoue, M., Perantoni, A. O., Buzard, G. S., Miki, H., Tanizawa, O., & Rice, J. M. (1991) · PubMed · Cited by 156
Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis
Hecht, J. L., Ince, T. A., Baak, J. P. A., Baker, H. E., Ogden, M. W., & Mutter, G. L. (2004) · Modern Pathology · doi:10.1038/modpathol.3800328 · Cited by 149
Self-citationPTEN, a Protean Tumor Suppressor
Mutter, G. L. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64656-1 · Cited by 147
Self-citationMutter, G. L., Baak, J. P. A., Fitzgerald, J. T., Gray, R. J., Neuberg, D. S., Kust, G. A., Gentleman, R. C., Gullans, S. R., Wei, L., & Wilcox, M. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6352 · Cited by 136
Self-citationIrving, J. A., Catasús, L., Gallardo, A., Bussaglia, E., Romero, M., Matías‐Guiu, X., & Prat, J. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.03.005 · Cited by 124
Internal hazards: baseline DNA damage by endogenous products of normal metabolism
Burcham, P. C. (1999) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5742(99)00008-3 · Cited by 114
Alkushi, A. O., Lim, P., Coldman, A. J., Huntsman, D. D., Miller, D. M., & Gilks, C. B. (2004) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200404000-00007 · Cited by 114
Mutter, G. L., Chaponot, M. L., & Fletcher, J. A. (1995) · Europe PMC (PubMed Central) · Cited by 113
Self-citationOuyang, H., Furukawa, T., Abé, T., Kato, Y., & Horii, A. (1998) · PubMed · Cited by 107
Whitcomb, B. P., Mutch, D. G., Herzog, T. J., Rader, J. S., Gibb, R. K., & Goodfellow, P. J. (2003) · PubMed · Cited by 103
Changes in Endometrial PTEN Expression throughout the Human Menstrual Cycle
Mutter, G. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.6.2334 · Cited by 100
Self-citationMutation and Cancer: The Antecedents to Our Studies of Adaptive Mutation
Cairns, J. (1998) · Genetics · doi:10.1093/genetics/148.4.1433 · Cited by 99
Mutter, G. L., Boynton, K. A., Faquin, W. C., Ruiz, R., & Jovanovic, A. (1996) · PubMed · Cited by 96
Self-citationJovanovic, A., Boynton, K. A., & Mutter, G. L. (1996) · PubMed · Cited by 94
Self-citationBaak, J. P. A., Nauta, J. J. P., Wisse-Brekelmans, E. C. M., & Bezemer, P. D. (1988) · The Journal of Pathology · doi:10.1002/path.1711540409 · Cited by 94
Dunton, C. J., Baak, J. P. A., Palazzo, J., van Diest, P. J., McHugh, M., & Widra, E. A. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70599-9 · Cited by 87
Skov, B. G., Broholm, H., Engel, U., Franzmann, M. B., Nielsen, A. L., Lauritzen, A. F., & Skov, T. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199701000-00006 · Cited by 87
Baak, J. P. A., Wisse-Brekelmans, E. C. M., Fleege, J. C., van der Putten, H. W. H. M., & Bezemer, P. D. (1992) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80244-x · Cited by 85
PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
Zhu, X., Kwon, C. H., Schlosshauer, P. W., Ellenson, L. H., & Baker, S. J. (2001) · PubMed · Cited by 81
Wang, S. A., Pudney, J., Song, J. H., Mor, G., Schwartz, P. E., & Zheng, W. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(02)00008-2 · Cited by 73
Discovery of Epigenetically Masked Tumor Suppressor Genes in Endometrial Cancer
Takai, N., Kawamata, N., Walsh, C., Gery, S., Desmond, J. C., Whittaker, S., SAID, J. W., Popoviciu, L. M., Jones, P. A., Miyakawa, I., et al. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0110 · Cited by 73
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Saito, T., Nishimura, M., Yamasaki, H., & Kudo, R. (2003) · Cancer · doi:10.1002/cncr.11157 · Cited by 65
Shih, H., Shiozawa, T., Miyamoto, T., Kashima, H., Feng, Y.-Z., Kurai, M., & Konishi, I. (2004) · PubMed · Cited by 63
Involvement of mammalian MLH1 in the apoptotic response to peroxide-induced oxidative stress.
Hardman, R. A., Afshari, C. A., & Barrett, J. C. (2001) · PubMed · Cited by 62
Mutter, G. L., Wada, H., Faquin, W. C., & Enomoto, T. (1999) · Molecular Pathology · doi:10.1136/mp.52.5.257 · Cited by 61
Self-citationSaegusa, M., Hashimura, M., Kuwata, T., 浜野, 美., & Okayasu, I. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700273 · Cited by 58
Risinger, J. I., Maxwell, G. L., Chandramouli, G. V. R., Aprelikova, O. N., Litzi, T. A., Umar, A., Berchuck, A., & Barrett, J. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-0850 · Cited by 57
III. Endometrial Hyperplasia: Is It Time for a Quantum Leap to a New Classification?*
Zaino, R. J. (2000) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200010000-00004 · Cited by 51
Catasús, L., Matías‐Guiu, X., Machín, P. F., Zannoni, G. F., Scambia, G., Panici, P. B., & Prat, J. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2290::aid-cncr13>3.0.co;2-i · Cited by 51
Expression of E-Cadherin and α-, β-, γ-Catenin Proteins in Endometrial Carcinoma
Kim, Y. T., Choi, E. K., Kim, J. W., Kim, D. K., Kim, S. H., & Yang, W. I. (2002) · Yonsei Medical Journal · doi:10.3349/ymj.2002.43.6.701 · Cited by 37
Noonan, F. C., Mutch, D. G., Mallon, M. A., & Goodfellow, P. J. (2001) · Genomics · doi:10.1006/geno.2001.6590 · Cited by 36
p27 and Cyclin D1 Abnormalities in Uterine Papillary Serous Carcinoma
Schmitz, M. J., Hendricks, D. T., Farley, J. H., Taylor, R. R., Geradts, J., Rose, G. S., & Birrer, M. J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5814 · Cited by 36
Absence of PTEN Repeat Tract Mutation in Endometrial Cancers with Microsatellite Instability
Cohn, D. E., Basil, J., Venegoni, A. R., Mutch, D. G., Rader, J. S., Herzog, T. J., Gersell, D. J., & Goodfellow, P. J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5900 · Cited by 33
TP53 overexpression in recurrent endometrial carcinoma
Pijnenborg, J. M. A., van de Broek, L., de Veen, G. C. D., Roemen, G. M. J. M., de Haan, J., van Engeland, M., Voncken, J. W., & Groothuis, P. G. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.09.056 · Cited by 31
(2000) · Pure Amsterdam UMC · doi:10.1002/1097-0142(20001015)89:8
Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Cited by
EGFR Antagonists in Cancer Treatment
Ciardiello, F., & Tortora, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707704 · Cited by 2,058
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Setiawan, V. W., Yang, H. P., Pike, M. C., McCann, S. E., Yu, H., Xiang, Y.-B., Wolk, A., Wentzensen, N., Weiss, N. S., Webb, P. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.2596 · Cited by 827
Makker, V., MacKay, H., Ray-Coquard, I., Levine, D. A., Westin, S. N., Aoki, D., & Oaknin, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00324-8 · Cited by 674
The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
Slomovitz, B. M., & Coleman, R. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0662 · Cited by 397
Aghajanian, C., Sill, M. W., Darcy, K. M., Greer, B., McMeekin, D. S., Rose, P. G., Rotmensch, J., Barnes, M. N., Hanjani, P., & Leslie, K. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.6397 · Cited by 326
Metadata
- Authors
- Hecht, J. L., & Mutter, G. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-10-10
- Volume
- 24
- Issue
- 29
- Pages
- 4783-4791
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1979652171
- Cited by
- 535
- References
- 87
- FWCI
- 35.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.